Back
Simplify Opportunistic Income ETF Vs. MiNK Therapeutics, Inc. Sector Stock Comparison
Buy
52
CRDT
Simplify Opportunistic Income ETF
Last Price:
$23.30
Seasonality Move:
1.44%
Sell
32
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.68
Seasonality Move:
-18.07%
Buy
52
Simplify Opportunistic Income ETF (CRDT)
is a Buy
Is Simplify Opportunistic Income ETF a Buy, Sell or Hold?
-
The current Simplify Opportunistic Income ETF [CRDT] share price is $23.40. The Score for CRDT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
CRDT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.59. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRDT Stock Price Chart
What is Simplify Opportunistic Income ETF's stock price today?
-
The Simplify Opportunistic Income ETF share price today is $23.40The current trend is relatively stagnant and CRDT is experiencing slight buying pressure.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight buying pressure.
CRDT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 58.71 | Buy |
| Chaikin Money Flow: | 40301 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.17 - 23.39) | Buy |
| Bollinger Bands (100): | (23.32 - 23.98) | Sell |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 44.79 | Sell |
| Chaikin Money Flow: | 9780 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.89 - 12.35) | Sell |
| Bollinger Bands (100): | (12.23 - 15.15) | Sell |
CRDT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.23 | Buy |
| 20-day SMA: | 23.26 | Buy |
| 50-day SMA: | 23.37 | Buy |
| 200-day SMA: | 24.22 | Sell |
| 8-day EMA: | 23.28 | Buy |
| 20-day EMA: | 23.27 | Buy |
| 50-day EMA: | 23.39 | Buy |
| 200-day EMA: | 24.04 | Sell |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.09 | Sell |
| 20-day SMA: | 11.62 | Sell |
| 50-day SMA: | 12.8 | Sell |
| 200-day SMA: | 11.89 | Sell |
| 8-day EMA: | 11.86 | Sell |
| 20-day EMA: | 11.96 | Sell |
| 50-day EMA: | 12.6 | Sell |
| 200-day EMA: | 12.22 | Sell |
Simplify Opportunistic Income ETF Earnings Growth & CRDT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Simplify Opportunistic Income ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||